投資評等
最後更新日期：2025/4/4
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2013/3/14 | RBC Capital Mkts | Sector Perform >> Outperform | $90 >> $110 |
| 2011/12/27 | Oppenheimer | Perform >> Outperform | 100 |
| 2011/12/22 | Wunderlich | Hold >> Buy | 95 |
| 2011/8/16 | Barclays Capital | Equal Weight >> Overweight | $104 >> $114 |
| 2010/5/26 | RBC Capital Mkts | Sector Perform >> Outperform | $63 >> $75 |
| 2010/4/21 | JMP Securities | Mkt Perform >> Mkt Outperform | |
| 2009/10/12 | Jefferies & Co | Underperform >> Hold | $30 >> $40 |
| 2009/7/23 | Needham | Hold >> Buy | 42 |
| 2009/7/20 | Caris & Company | Below Average >> Average | $18 >> $29 |
| 2009/7/14 | Jefferies & Co | Underperform >> Hold | $20 >> $25 |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2015/1/28 | Needham | Buy >> Hold | |
| 2013/1/29 | MKM Partners | Buy >> Neutral | $125 >> $77 |
| 2009/8/10 | Jefferies & Co | Hold >> Underperform | 30 |
| 2009/4/23 | JP Morgan | Overweight Neutral | |
| 2009/4/23 | Lazard Capital Mkts | Hold Sell | |
| 2009/4/23 | Jefferies & Co | Hold Underperform | |
| 2008/11/21 | UBS | Neutral Sell | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2014/3/17 | Monness Crespi & Hardt | Buy | 125 |
| 2013/2/28 | Stifel Nicolaus | Hold | |
| 2011/12/6 | Barclays Capital | Overweight | 115 |
| 2011/1/20 | Collins Stewart | Hold | 92 |
| 2010/11/19 | Wunderlich | Hold | 80 |
| 2010/10/8 | FBR Capital | Mkt Perform | 82 |
| 2009/9/9 | Morgan Keegan | Mkt Perform | |
| 2009/8/27 | AmTech Research | Buy | 40 |
| 2009/6/3 | Ladenburg Thalmann | Sell | 26 |
| 2009/3/27 | Auriga U.S.A | Sell | 18 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2014/9/10 | MKM Partners | Buy | 117 |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2015/10/12 | MKM Partners | Buy | $100 >> $90 |
| 2015/10/12 | Monness Crespi & Hardt | Buy | $102 >> $95 |
| 2014/10/22 | UBS | Buy | $125 >> $106 |
| 2013/1/29 | Oppenheimer | Outperform | $110 >> $100 |
| 2012/7/9 | Wunderlich | Buy | $120 >> $100 |
| 2012/4/19 | UBS | Buy | $115 >> $125 |
| 2011/4/20 | RBC Capital Mkts | Outperform | $100 >> $110 |
| 2011/4/20 | FBR Capital | Mkt Perform | $83 >> $97 |
| 2011/4/20 | ISI Group | Buy | $110 >> $115 |
| 2011/1/25 | Deutsche Bank | Hold | $78 >> $95 |